Mansour Aly, Dina
Dwivedi, Om Prakash http://orcid.org/0000-0001-8670-7717
Prasad, Rashmi B. http://orcid.org/0000-0002-4400-6741
Käräjämäki, Annemari
Hjort, Rebecka
Thangam, Manonanthini http://orcid.org/0000-0002-7164-6525
Åkerlund, Mikael
Mahajan, Anubha
Udler, Miriam S. http://orcid.org/0000-0003-3824-9162
Florez, Jose C. http://orcid.org/0000-0002-1730-9325
McCarthy, Mark I.
Abecasis, Goncalo
Baras, Aris
Cantor, Michael
Coppola, Giovanni
Economides, Aris
Lotta, Luca A.
Overton, John D.
Reid, Jeffrey G.
Shuldiner, Alan
Beechert, Christina
Forsythe, Caitlin
Fuller, Erin D.
Gu, Zhenhua
Lattari, Michael
Lopez, Alexander
Schleicher, Thomas D.
Padilla, Maria Sotiropoulos
Widom, Louis
Wolf, Sarah E.
Pradhan, Manasi
Manoochehri, Kia
Ulloa, Ricardo H.
Bai, Xiaodong
Balasubramanian, Suganthi
Blumenfeld, Andrew
Eom, Gisu
Habegger, Lukas
Hawes, Alicia
Khalid, Shareef
Maxwell, Evan K.
Salerno, William
Staples, Jeffrey C.
Jones, Marcus B.
Mitnaul, Lyndon J.
Brosnan, Julia
Melander, Olle
Carlsson, Sofia
Hansson, Ola http://orcid.org/0000-0002-7394-7639
Tuomi, Tiinamaija http://orcid.org/0000-0002-8306-6202
Groop, Leif http://orcid.org/0000-0002-0187-3263
Ahlqvist, Emma http://orcid.org/0000-0002-6513-2384
,
,
,
,
,
Article History
Received: 12 October 2020
Accepted: 7 September 2021
First Online: 4 November 2021
Competing interests
: The views expressed in this article are those of the authors and not necessarily those of the National Health Service, National Institute for Health Research or Department of Health. M.I.M. has served on advisory panels for Pfizer, Novo Nordisk and Zoe Global, has received honoraria from Merck, Pfizer, Novo Nordisk and Eli Lilly and research funding from AbbVie, AstraZeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, Servier and Takeda. As of June 2019, M.I.M. is an employee of Genentech and a holder of Roche stock. As of January 2020, A.M. is an employee of Genentech and a holder of Roche stock. J.B. is an employee and shareholder of Pfizer. J.C.F. has received consulting honoraria from Goldfinch Bio and speaking honoraria from Novo Nordisk. The other authors declare no competing interests.